Compare Pfizer Inc (PFE) vs SYSCO Corporation (SYY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs SYSCO Corporation — how do they compare? Pfizer Inc trades at $28.06 (market cap $158.56B), while SYSCO Corporation trades at $78.09 (market cap $38.47B). The key difference: Pfizer Inc is far larger — about 4.1× SYSCO Corporation's market cap, and Pfizer Inc pays the higher dividend (6.18%). Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and SYSCO Corporation for 77 Days on average.
| PFE | SYY | |
|---|---|---|
Market Cap | $158.56B | $38.47B |
Volume | 44,138,282 | 4,808,465 |
Sector | Health | Consumer Staples |
52-Week High | $29.02 | $91.16 |
52-Week Low | $23.67 | $69.30 |
Typical Hold Time | 158 Days | 77 Days |
Enterprise Value | $210.06B | $51.65B |
Dividend Yield | 6.18% | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
Sysco Corporation (SYY) trades at $76.79, down 0.85% with a bearish technical outlook. The company shows solid revenue growth to $81.37B in 2025 but faces margin compression with net income margin at 2.08%. Recent developments include a $500M AI efficiency program and a $1.5B senior notes offering. Analyst consensus remains positive with 60% buy ratings and an $85.75 price target, representing 11.7% upside potential.
SYY offers value with a P/S ratio of 0.44x and dividend yield support, but faces execution risks on margin improvement and debt management. The stock trades below analyst targets, providing potential upside if the company delivers on its AI efficiency goals and maintains market leadership in food distribution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About SYSCO Corporation
Sysco is the largest U.S. food-service distributor, boasting 17% market share of the highly fragmented food-service distribution industry. Sysco distributes over 400,000 food and nonfood products to restaurants (63% of revenue), healthcare facilities (8%), education and government buildings (8%), travel and leisure (7%), and other locations (14%) where individuals consume away-from-home meals. In fiscal 2022, 82% of the firm's revenue was U.S.-based, with 7% from Canada, 4% from the U.K., 2% from France, and 4% other.
Read more on SYY →
